Mutation analysis of the BRCA1-interacting genes FANCD2, BRIP1/BACH, LMO4 and SFN in a large number of non-BRCA1/2 breast cancer families did not identify any highly penetrant, pathogenic mutations. This evidence concerns the gene LMO4 and breast carcinoma.